Olipudase alfa-rpcp Injection
Sanofi-Aventis U.S. LLC · Available
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 11/16/2026
- Package NDC
- 58468-0050-1
- Generic name
- Olipudase alfa-rpcp Injection
- Contact info
- 888-847-4877
- Availability
- Available
- Update date
- 11/19/2026
- Dosage form
- Injection
- Presentation
- Xenpozyme, Injection, 20 mg/5.1 mL (NDC 58468-0050-1)
- Company name
- Sanofi-Aventis U.S. LLC
- Status
- Current
- Related info
Supply concerns for late November through early December 2026; See the following site for additional information from Sanofi: https://www.sanofi.com/en/our-science/therapeutic-areas/rare-diseases/supply-update
- Therapeutic category
- Endocrinology/Metabolism
- Harmonized identifiers (openFDA)
- Application number
- BLA761261
- Brand name
- XENPOZYME
- Generic name
- OLIPUDASE ALFA-RPCP
- Manufacturer name
- Genzyme Corporation
- Product NDC
- 58468-0050, 58468-0051
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- OLIPUDASE ALFA
- RxCUI
- 2610411, 2610416, 2634357, 2634359
- SPL ID
- ce8d4153-ce95-43c4-9672-e1e951ebcdaa
- SPL set ID
- 01a910ee-a33e-4be3-ac41-322d64c34311
- Package NDC
- 58468-0050-1, 58468-0051-1
- UNII
- 6D5766Q4OP
